Citius Pharmaceutical $CTXR Mino-Lok™ Phase 3 Clinical Trial Ready
5 Feb
2018
Written by Mike Elliott

Citius Pharmaceutical $CTXR Mino-Lok™ Phase 3 Clinical Trial Ready »

Citius is a specialty pharmaceutical company dedicated to the development and commercialization of unique therapeutic products in adjunctive cancer care with a focus on infectious diseases.

Read more...

Login

Lost your password?